Sales Development Representative, DNA Script
Innovations in DNA synthesis for biological development
Be an early applicant
Innovations in DNA synthesis for biological development
101-200 employees
Be an early applicant
101-200 employees
Company mission
To accelerate breakthroughs in life science and human health.
Role
Who you are
- Bachelor’s in Biology, Molecular Biology, Biochemistry, or related field
- 2+ years lab experience (e.g. synthetic biology, genomics, qPCR, NGS); sales experience a plus
- Ability to quickly grasp and explain technical concepts
- Excellent communication skills — confident, curious, and persuasive
- Self-starter mindset with a strong drive to exceed goals
Desirable
- Experience in life science sales or inside sales roles
- Familiarity with CRM tools and lead generation platforms
- Passion for biotech innovation and a startup mentality
What the job involves
- This is an opportunity for a dynamic individual to join an international and highly skilled team, and to make significant contributions to commercializing a technology with far-reaching potential across the biological sciences and beyond
- We are seeking a Sales Development Representative (SDR) to join our growing commercial team
- This is an opportunity to join a cutting-edge biotech startup and play a crucial role in expanding our customer base across North America
- As a Sales Development Representative, you’ll be the first point of contact for prospective customers — understanding their needs, introducing them to SYNTAX, and setting the stage for successful partnerships
- You’ll work hand-in-hand with field sales to drive growth and revenue
- Qualify inbound leads and conduct targeted outbound outreach
- Engage prospects via phone, email, and virtual demos
- Translate complex molecular biology concepts into customer-focused solutions
- Collaborate with sales, marketing, and technical teams to deliver value
- Maintain clean, accurate CRM data to support pipeline growth
Our take
Outsourcing DNA synthesis can be a large problem for R&D labs, as unprecedented factors such as delivery delays or issues on arrival can lead to schedule alterations and material that is no longer suitable for use. DNA Script attempts to solve this issue by democratising DNA synthesis for laboratories everywhere.
DNA Script facilitates biological and scientific development through providing proprietary equipment to labs that facilitate in-house DNA synthesis. The equipment eliminates the need for a reliance on external sources, and can significantly speed up workflows and operational efficiencies.
An issue found with equipment is that the DNA synthesised may vary in quality across locations, a problem that the company is committed to addressing through investigations and evaluation. By increasing the ability of labs to carry out DNA synthesis, the possibilities of the tech are vast and have the potential for revolutionary scientific developments. 2022 funding has facilitated the advance of DNA Script's SYNTAX Platform, allowing scientists to print synthetic nucleic acids, avoiding the need for third-party waiting times.
Steph
Company Specialist at Welcome to the Jungle
Insights
14% employee growth in 12 months
Company
Funding (last 2 of 8 rounds)
Jan 2022
$35m
SERIES C
Oct 2021
$165m
SERIES C
Total funding: $311.9m
Company HQ
Le Kremlin-Bicêtre, France
Leadership
Thomas Ybert
(Co-Founder & CSO)Previously a Metabolic Engineering Project Leader at Amyris and a Biotechnological Senior Scientist at TOTAL.
Xavier Godron
(Co-Founder & CTO)Previously an Analyst at TOTAL and an Engineer at Akuo Energy.
Sylvain Gariel
(Co-Founder & COO)Previously a Research Analyst at TOTAL, a Business Analyst at URGO, and a Mining Engineer for the French Ministry of Industry. Also worked as a Portfolio Manager for a state shareholding agency.
Share this job
View 1 more job at DNA Script